Officer exercised or converted 9,344 JNJ derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Aug 6, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Aug 7, 2026
OfficerOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000200406-26-000169
Filed / recordedAug 7, 2026, 9:44 PM UTCAdded to OQROOct 2, 2026, 3:52 AM UTC Data qualityVerified: identifiers matched exactly Reporting personElizabeth Forminard Officer titleEVP, Chief Legal Officer SecurityEmployee Stock Options (Right to Buy) TableDerivative (Table II) Transaction dateAug 6, 2026 Acquired / disposedDisposed (D) Footnotes from the filing
- Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Around the same time
Derivative exercise or conversion — not an open-market buy.
37K → 25K shares held−30% of their stake
Johnson & Johnson's WW Chair, MedTech sold $3.04M of Johnson & Johnson shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.